decisionhealth Newsletters, Part B News - 2014 Issue 10 (October)
Biggest gains, drops in ASP pricing from Q3 to Q4 2014
Subscribe or sign in to view the full article.
Article Overview
This article summarizes notable shifts in CMS average sales price (ASP) drug pricing between Q3 and Q4 2014. It is useful for healthcare billing and coding professionals who track Medicare drug pricing updates and want to understand which commonly reported items experienced the largest price movements during that release cycle.
Why This Topic Matters
Quarterly ASP updates can affect reimbursement awareness, charge review workflows, and price monitoring for injectable drugs and related products. This piece helps readers quickly identify the scope of the CMS pricing release without needing to scan the full table.
What You Will Learn
- The article’s focus within the CMS quarterly ASP pricing release
- Which pricing changes were grouped as top gainers and top losers
- The categories of products included in the summary table
- How the article frames quarter-to-quarter ASP movement for Q3 to Q4 2014
Who Should Read This
- Medical coders
- Billing specialists
- Reimbursement analysts
- Practice managers
- Healthcare revenue cycle staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com